• 1. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 2. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 3. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 4. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 5. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazanaphthalenes Naphthyridines

Introduction to 1,5-Naphthyridine-3-carbaldehyde (CAS No. 959617-49-3)

1,5-Naphthyridine-3-carbaldehyde, with the chemical identifier CAS No. 959617-49-3, is a significant compound in the realm of pharmaceutical and biochemical research. This heterocyclic aldehyde derivative belongs to the naphthyridine family, a class of nitrogen-containing heterocycles that have garnered considerable attention due to their diverse biological activities and structural versatility. The compound's unique structural features, characterized by a fused bicyclic system containing two nitrogen atoms, make it a valuable scaffold for the development of novel therapeutic agents.

The 1,5-naphthyridine core exhibits remarkable stability and reactivity, which are harnessed in synthetic chemistry for the construction of more complex molecules. The presence of an aldehyde group at the 3-position further enhances its utility as a synthetic intermediate, enabling various functionalization strategies. These attributes have positioned 1,5-naphthyridine-3-carbaldehyde as a key building block in medicinal chemistry, particularly in the pursuit of drugs targeting neurological and inflammatory disorders.

Recent advancements in the field of drug discovery have highlighted the potential of 1,5-naphthyridine derivatives as modulators of enzyme activity and receptor binding. For instance, studies have demonstrated that modifications at the 3-position of the naphthyridine ring can significantly influence binding affinity and selectivity for biological targets. This has spurred interest in exploring 1,5-naphthyridine-3-carbaldehyde as a precursor for designing molecules with enhanced pharmacological properties.

One particularly intriguing application lies in its role as a precursor for kinase inhibitors. Kinases are enzymes that play crucial roles in cell signaling pathways, and their dysregulation is implicated in numerous diseases, including cancer. The aldehyde functionality in 1,5-naphthyridine-3-carbaldehyde allows for facile coupling with amines or other nucleophiles to form Schiff bases or other derivatives that can interact with kinase active sites. Such interactions have been explored in the development of small-molecule inhibitors that exhibit promising preclinical activity against various kinases.

Moreover, the 1,5-naphthyridine scaffold has shown promise in addressing neurological disorders. Research indicates that this moiety can penetrate the blood-brain barrier, making it an attractive candidate for central nervous system (CNS) drug development. Specifically, derivatives of 1,5-naphthyridine-3-carbaldehyde have been investigated for their potential to modulate neurotransmitter systems involved in conditions such as Alzheimer's disease and Parkinson's disease. The aldehyde group provides a handle for further derivatization to optimize solubility and bioavailability, which are critical factors for CNS drug delivery.

In addition to its applications in kinase inhibition and CNS drug development, 1,5-naphthyridine-3-carbaldehyde has been explored in anti-inflammatory research. Inflammatory processes are mediated by complex signaling pathways involving various enzymes and receptors. The structural flexibility of the 1,5-naphthyridine core allows for the design of molecules that can interfere with key inflammatory mediators. For example, studies have shown that certain derivatives can inhibit lipoxygenase and cyclooxygenase enzymes, which are central players in inflammation. The aldehyde group at the 3-position serves as a reactive site for covalent bond formation or further functionalization to enhance target engagement.

The synthesis of 1,5-naphthyridine-3-carbaldehyde involves multi-step organic transformations that highlight its synthetic utility. Traditional approaches often begin with commercially available naphthyridine precursors followed by functional group interconversion to introduce the aldehyde moiety at the desired position. Advances in catalytic methods have also enabled more efficient synthetic routes, reducing reaction times and improving yields. These developments make 1,5-naphthyridine-3-carbaldehyde accessible for large-scale production required for industrial applications.

The chemical properties of 1,5-naphthyridine-3-carbaldehyde, including its solubility profile and stability under various conditions, are critical considerations for its pharmaceutical applications. Solubility is particularly important for drug formulation, as it affects bioavailability and therapeutic efficacy. Modifications to improve solubility while maintaining biological activity are an active area of research. Additionally, stability under storage conditions ensures long-term viability of pharmaceutical products derived from this compound.

Evaluation of 1,5-naphthyridine-3-carbaldehyde often involves spectroscopic techniques such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS) to confirm molecular structure and purity. Computational methods like molecular modeling are also employed to predict interactions with biological targets and optimize lead compounds during drug discovery processes. These analytical tools collectively provide a comprehensive understanding of the compound's behavior both in vitro and in silico.

The future prospects for 1,5-naphthyridine-3-carbaldehyde are promising given its versatility as a pharmacophore. Ongoing research aims to expand its applications into new therapeutic areas by exploring novel derivatives with enhanced properties. Collaborative efforts between academic institutions and pharmaceutical companies are likely to accelerate the discovery pipeline using this compound as a starting point. As our understanding of biological systems continues to evolve, so too will the innovative uses of 1,5-naphthyridine derivatives, including those derived from 1,5-naphthyridine-3-carbaldehyde.

• 179381-15-8(Pyrrolo[1,2-a]pyrazine-8-carbaldehyde)
• 25957-65-7(1H-Pyrrolo[2,3-c]pyridine-3-carbaldehyde)
• 56671-64-8(Indolizine-1-carbaldehyde)
• 80231-38-5(7-Methylquinoline-3-carbaldehyde)
• 141234-08-4(Quinoxaline-5-carbaldehyde)
• 13669-42-6(quinoline-3-carbaldehyde)
• 1020056-33-0(1H-Pyrrolo3,2-bpyridine-6-carbaldehyde)
• 64379-44-8(1,5-naphthyridine-4-carbaldehyde)
• 276862-85-2(1H-Pyrrolo[3,2-b]pyridine-3-carbaldehyde)
• 90418-64-7(1,5-Naphthyridine-3-carboxylic acid)